Vismodegib

Records for this ingredient, by country (identity only).

ATC L01XJ01 · 9 markets · 12 records

Vismodegib 9 markets · 12 records Forms

Filters

MarketAU 3 CA 2 US 1 GB 1 ES 1 TW 1 EU 1 FR 1

Strength

AU 3 records · 1 shown of 1 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

150 mgcapsuleERIVEDGE+1ERIVEDGE vismodegib 150 mg hard capsule bottle also in CA·US·GB
+3Other 3 markets
ES TW FR
unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ERIVEDGE ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

150 mgcapsuleERIVEDGE+1SPC-VISMODEGIB also in AU·US·GB
+3Other 3 markets
ES TW FR

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

150 mgcapsuleERIVEDGE also in AU·CA·GB
+3Other 3 markets
ES TW FR

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

150 mgcapsuleERIVEDGE also in AU·CA·US
+3Other 3 markets
ES TW FR

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

150 mgcapsuleERIVEDGE also in AU·CA·US
+3Other 3 markets
GB TW FR

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

150 mgcapsuleERIVEDGE+1愛維德膠囊150毫克 also in AU·CA·US
+3Other 3 markets
GB ES FR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ERIVEDGE ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

150 mgcapsuleERIVEDGE 150 mg, gélule also in AU·CA·US
+3Other 3 markets
GB ES TW

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	TW	EU	FR
150 mg capsule	ERIVEDGE	ERIVEDGE	ERIVEDGE SPC-VISMODEGIB	ERIVEDGE ERIVEDGE vismodegib 150 mg hard capsule bottle	ERIVEDGE	ERIVEDGE 愛維德膠囊150毫克	not recorded	ERIVEDGE 150 mg, gélule
not disclosed unknown	not recorded	not recorded	not recorded	ERIVEDGE	not recorded	not recorded	ERIVEDGE	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.